Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from TMO

Women's Rugby World Cup: France forward to appeal 12-game ban for biting

Les Bleues face the Red Roses in the last four this weekend

Evening Standard

Is Thermo Fisher Scientific Stock Underperforming the Dow?

Thermo Fisher Scientific has lagged behind the Dow Jones Industrial over the past year, but analysts maintain a strong bullish outlook on its future performance.

Barchart

Thermo Fisher Positioned As Biopharma's Partner Of Choice

Could Thermo Fisher Scientific Inc. (NYSE:TMO) be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strategic acquisitions and robust growth potential. William Blair initiated coverage on Tuesday on Thermo Fisher Scientific, citing a strong…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

This Thermo Fisher Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Is Wall Street Bullish or Bearish on Thermo Fisher Scientific Stock?

While Thermo Fisher Scientific has underperformed the broader market over the past year, Wall Street analysts continue to hold a bullish view of the stock’s long-term prospects.

Barchart

Why Thermo Fischer Stock Is Rising Wednesday

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, beating the street view of $5.23.

Benzinga

Beware the rectangle of doom: rugby union must heed lessons of Harry Potter drama

When a toenail in touch by a defending team results in a try being chalked off for those on the attack, the game is making itself look idiotic

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Here's What to Expect From Thermo Fisher Scientific's Next Earnings Report

Thermo Fisher Scientific is poised to release its second-quarter results later this month, and analysts project a single-digit earnings drop.

Barchart

Is Quest Diagnostics Stock Outperforming the Nasdaq?

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

How Is Waters Corporation's Stock Performance Compared to Other Healthcare Stocks?

Even though Waters Corporation has outshined the industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

Traders Eye a Breakout in Thermo Fisher Scientific (TMO) Amid Market Undercurrents

While TMO stock has represented one of the biggest market losers, a sentiment reversal could be in the works.

Barchart

Is Thermo Fisher Scientific Stock Underperforming the Nasdaq?

Thermo Fisher Scientific has notably underperformed the Nasdaq Composite over the past year, yet analysts remain bullish about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Thermo Fisher Scientific Stock?

Although Thermo Fisher Scientific has lagged behind the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Newcastle boss Steve Diamond banned after directing obscenity towards match officials

The Newcastle director of rugby was hit with a six-match ban last week

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Steve Diamond’s season-ending ban was for profanity aimed at match officials

Steve Diamond’s season-ending ban came because he hit out at a group of match-day officials before telling the TMO he should retire

Barchart

Earnings Preview: What to Expect From Thermo Fisher Scientific's Report

Thermo Fisher Scientific will release its first-quarter earnings later this month, and analysts anticipate bottom-line to remain unchanged year over year.

Barchart

Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Although Thermo Fisher Scientific has lagged behind the broader S&P 500 index over the past year, analysts remain confident in its long-term growth prospects.

Barchart

What Are Wall Street Analysts’ Target Price for Thermo Fisher Scientific Stock?

Thermo Fisher Scientific has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Mould, money and murder accusations – residents try to oust management on their London housing estate

The organisation managing the Loughborough Estate in Lambeth is beset by complaints of disrepair, damp and vermin – and has made some big claims of its own

MarketBeat

Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase

Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch.

Barchart

Thermo Fisher Scientific's Quarterly Earnings Preview: What You Need to Know

Thermo Fisher Scientific is expected to announce its fourth-quarter results later this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

StockNews.com

3 Healthcare Stocks to Buy Now for a Healthy Portfolio in 2025

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

Barchart

How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?

While Thermo Fisher Scientific has underperformed the broader medical device industry recently, analysts remain optimistic about the company's future outlook.

Barchart

Thermo Fisher Scientific Stock: Is Wall Street Bullish or Bearish?

Despite Thermo Fisher Scientific’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Nasdaq Futures Fall on Higher Bond Yields Ahead of Tesla Earnings

December Nasdaq 100 E-Mini futures (NQZ24) are trending down -0.23% this morning as Treasury yields continued to rise on the prospect of less aggressive Federal Reserve interest rate cuts, while investors awaited a slew of corporate earnings reports, with a particular focus on results from “Magnificent Seven” member Tesla.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.